Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. (2014)
Attributed to:
Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(14)60162-8
PubMed Identifier: 24835842
Publication URI: http://europepmc.org/abstract/MED/24835842
Type: Journal Article/Review
Volume: 384
Parent Publication: Lancet (London, England)
Issue: 9944
ISSN: 0140-6736